Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis.
One calcitriol dose transiently increases Helios(+)FoxP3(+) T cells and ameliorates autoimmune demyelinating disease.
Revimmune (High-Dose Cyclophosphamide) for Autoimmune Diseases
The immunopathology of multiple sclerosis: an overview.
Inflammatory cortical demyelination in early multiple sclerosis.
Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD.
Biogen Third Quarter 2015 Revenues Increase 11% to $2.8 Billion; Company Raises 2015 Full Year Guidance
Effect of Glatiramer Acetate on Peripheral Blood Brain-Derived Neurotrophic Factor and Phosphorylated TrkB Levels in Relapsing-Remitting Multiple Sclerosis.
Stopping Disease Modifying Therapy in Progressive Multiple Sclerosis - A Prospective Study
Impact of cladribine on soluble adhesion molecules in multiple sclerosis.
Imovane: Best Online Pharmacy
No Differences Observed among Multiple Clinical S1P1 Receptor Agonists (Functional Antagonists) in S1P1 Receptor Down-regulation and Degradation.
The potential teratogenic effects of interferon beta-1a (IFNβ-1a) and interferon beta-1b (IFNβ-1b) on in vitro embryonic development.
Prevalence of neurological disorders in Al Quseir, Egypt: methodological aspects.
Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE).
Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder.
Recurrent brainstem lesions mimicking infarctions in an elderly patient with neuromyelitis optica spectrum disorder.
Novel MS Drug Offers Good Functional Outcomes
Gordon Research Conference on Glia Biology: Functional Interactions among Glia & Neurons
Keystone Symposium: Advances in the Knowledge and Treatment of Autoimmunity
Development of cladribine at Scripps for hairy cell leukemia and current results.
Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years.
Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis.
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.
Gender identity disorders and multiple sclerosis risk: A national record-linkage study.

Pages